BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InfuSystem Holdings, Inc. (HAPN.OB) Modifies Bylaws to Align with Corporate Governance Best Practices


5/31/2012 10:39:41 AM

MADISON HEIGHTS, Mich., May 30, 2012 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU), the leading national provider of infusion pumps and related services for the healthcare industry, announced today it has implemented a number of substantive bylaw changes that enhance shareholder rights, as well as better align with ISS recommendations for corporate governance, including:

  • Reducing the percentage of shareholders required to call a special meeting of shareholders to 10 percent. It previously required a majority;
  • Shortening the notice requirement of shareholder director nominations and meeting proposals to 60-90 days from 90-120 days in advance of the anniversary of the prior year's meeting;
  • Allowing a majority of shareholders to act by written consent rather than the prior 100% requirement, providing a means for investors to consider and vote on matters that could arise between annual meetings; and
  • Changing to a majority, rather than plurality, voting requirement for election of director nominees.

The Board also voted to withdraw the Rights Agreement, dated as of November 12, 2010 (i.e., the "poison pill"), which will be effected shortly.

"The InfuSystem Board has affirmed its commitment to transparent communication, strong corporate governance practices, and the highest ethical standards consistent with our stewardship responsibilities," Executive Board Chairman Ryan Morris stated. "Boards, after all, serve at the pleasure of their shareholders. We firmly believe that acting in an owner-oriented fashion is the most responsible approach."

The Company also reported that its newly constituted Board of Directors, elected by shareholders, received more than 99% of the votes cast for election at this year's annual shareholders meeting on May 25, 2012.

"We appreciate this overwhelming vote of confidence from our shareholders," added Morris. "The duly elected Board, working in concert with the new management team here, have, in short order, established the foundation from which the Company intends to achieve operational and strategic growth, and increase shareholder value."

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The Company's stock is traded on the NYSE MKT under the symbol INFU.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the Company's publicly filed documents.

Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.

INVESTOR CONTACT:
Jonathan P. Foster
Chief Financial Officer
Info@InfuSystem.com
800-962-9656

SOURCE InfuSystem Holdings, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES